网站大量收购独家精品文档,联系QQ:2885784924

sphingosine 1-phosphate receptor 1 as a useful target for treatment of multiple sclerosis鞘氨醇1-phosphate受体1作为一个有用的治疗多发性硬化症的目标.pdfVIP

sphingosine 1-phosphate receptor 1 as a useful target for treatment of multiple sclerosis鞘氨醇1-phosphate受体1作为一个有用的治疗多发性硬化症的目标.pdf

  1. 1、本文档共15页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
sphingosine 1-phosphate receptor 1 as a useful target for treatment of multiple sclerosis鞘氨醇1-phosphate受体1作为一个有用的治疗多发性硬化症的目标

Pharmaceuticals 2012, 5, 514-528; doi:10.3390/ph5050514 OPEN ACCESS Pharmaceuticals ISSN 1424-8247 /journal/pharmaceuticals Review Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis Kenji Chiba * and Kunitomo Adachi Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan; E-Mail: Adachi.Kunitomo@mc.mt-pharma.co.jp (K.A.) * Author to whom correspondence should be addressed; E-Mail: Chiba.Kenji@mk.mt-pharma.co.jp; Tel.: +81-45-963-4342; Fax: +81-45-963-7316. Received: 5 April 2012; in revised form: 24 April 2012 / Accepted: 15 May 2012 / Published: 18 May 2012 Abstract: Sphingosine 1-phosphate (S1P), a lysophospholipid mediator, is generated from sphingosine by sphingosine kinases and binds five known cell surface receptors. S1P receptor 1 (S1P ) plays an essential role in lymphocyte egress from secondary lymphoid 1 organs (SLO), as evinced by the inability of lymphocytes to exit from the SLO in mice lacking lymphocytic S1P . Fingolimod hydrochloride (FTY720) is a first-in-class, orally 1 active, S1P receptor modulator with a structure closely related to sphingosine. FTY720 was first synthesized by chemical modification of a natural product, myriocin. FTY720 is effectively converted to an active metabolite, FTY720 phosphate (FTY720-P) by sphingosine ki

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档